57 Results
Register Now! Live with Leadership—A Conversation Commemorating National HIV Vaccine Awareness Day
Register now to take part in an important conversation about National HIV Vaccine Awareness Day—an annual observation to recognize the many community members, health professionals, and scientists working together to develop a vaccine to prevent HIV. The HIV.gov-hosted Live with Leadership conversation will take place on Thursday, May 18, from 2:30–3:00pm ET.
This engaging...
NIAID-Supported Study Provides Stronger Evidence of Link Between RSV and Childhood Asthma
The study found that infants who were not infected with RSV in the first year of life had a 26% lower risk of asthma at 5 years of age than those who were infected with RSV as infants.
Close-up view of protein-complex structures could lead to better flu vaccines
A new understanding of vaccine components gained through electron microscopy and other direct visualization techniques could help scientists design more effective seasonal influenza vaccines.
CROI 2023—Dr. Dieffenbach Shares Research Highlights on Long-Acting HIV Prevention and Treatment, COVID, and a Cure Update
Dr. Dieffenbach, Director of the Division of AIDS, shared updates about some research on long-acting HIV prevention and treatment and COVID treatment and prevention. He also discussed news of another reported case of HIV cure.
Novel Study Model Reveals New Understanding of Fatal Familial Insomnia
Fatal familial insomnia (FFI) is a little-known yet horrific disease in which people die from lack of sleep. In a new study, NIAID scientists developed a cerebral organoid model to study the exact protein mutation that causes FFI.
NIAID-led Work Identifies Bacteria Signaling for Nerve Repair in Mice
A team of NIAID-led researchers has identified a mechanism in mice in which the immune system and commensal bacteria help repair damaged sensory neurons within the skin. They hope their findings could lead to therapies that stimulate recovery in people following skin injury and limit damage from chemotherapy and chronic diseases.
NIAID-Supported Studies Identify Universal Predictors of Antibody Response to Vaccination
Two recently published studies explain why some people respond better to vaccines than others and could guide the development of new strategies to enhance the antibody response to vaccination.
